Second Sight Medical Products Inc

EYESW · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$3-$10-$6-$20
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.-$0$1$0$2
Change in WC-$0$0$0$1
Other Non-Cash-$1$1$1-$2
Operating Cash Flow-$4-$8-$5-$20
Investing Activities
PP&E Inv.-$1-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$14
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$6
Investing Cash Flow-$1-$0-$0$7
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$3$0$0$53
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3-$0-$0$70
Financing Cash Flow$3-$0-$0$70
Forex Effect$0$0-$0$0
Net Chg. in Cash-$4-$48-$5-$37
Supplemental Information
Beg. Cash$8$56$20$56
End Cash$4$8$14$20
Free Cash Flow-$5-$8-$5-$20
Second Sight Medical Products Inc (EYESW) Financial Statements & Key Stats | AlphaPilot